Fungifar Cream is a potent topical formulation combining Ciprofloxacin (1.0% w/w), Metronidazole (1.0% w/w), Terbinafine (1.0% w/w), and Clobetasol (0.05% w/w) designed to effectively treat a variety of mixed bacterial and fungal skin infections accompanied by inflammation. Ciprofloxacin, a broad-spectrum fluoroquinolone antibiotic, targets and eliminates susceptible bacterial pathogens, while Metronidazole provides additional antibacterial and antiprotozoal activity, particularly against anaerobic organisms. Terbinafine, an allylamine antifungal agent, inhibits fungal cell membrane synthesis, making it effective against dermatophytes and other fungal infections. Clobetasol, a potent corticosteroid, reduces inflammation, redness, and itching, providing symptomatic relief and accelerating healing. This combination is especially useful in complicated infections where both bacterial and fungal pathogens coexist, often accompanied by significant inflammatory responses. Fungifar Cream should be applied topically as directed by a healthcare professional, typically once or twice daily, to the affected area after cleansing. It is important to use the medication for the full prescribed duration to prevent recurrence and resistance. Patients should avoid contact with eyes and mucous membranes and discontinue use if irritation or hypersensitivity occurs. Fungifar Cream offers a comprehensive approach to managing complex dermatological infections with combined antimicrobial and anti-inflammatory effects.